Found 35 Enz. Inhib. hit(s) with all data for entry = 50008824 
Affinity DataKi: 19nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 22nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 29nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 32nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 36nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 44nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 57nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 85nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 86nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 86nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 100nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 100nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 110nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 114nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 115nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 115nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 125nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 144nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 150nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 175nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 199nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 255nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 260nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 285nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 650nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 700nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 800nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 1.10E+3nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 1.25E+3nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 1.35E+3nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 1.35E+3nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 1.65E+3nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: >2.60E+3nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 2.80E+3nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
Affinity DataKi: 3.00E+3nMAssay Description:Antagonist activity at full length human recombinant GCGR transfected in HEK293 cells assessed as inhibition of glucagon-stimulated cAMP by by LANCE ...More data for this Ligand-Target Pair
